Abstract:Reactivated varicella-zoster virus (VZV), which lies latent in the dorsal root ganglions and cranial nerves before its reactivation, is capable of causing herpes zoster (HZ), but the specific mechanism of virus reactivation and latency remains unknown. It was proposed that circulating microRNAs (miRNAs) in body fluids could potentially indicate infection. However, the connection between herpes zoster and circulating miRNAs has not been demonstrated. In this study, 41 HZ patients without superinfection were selected. The serum miRNA levels were analyzed by TaqMan low density array (TLDA) and confirmed individually by quantitative reverse transcription PCR (RT-qPCR) analysis. Thirty-five age-matched subjects without any infectious diseases or inflammation were selected as controls. The results showed that the serum miRNA expression profiles in 41 HZ patients were different from those of control subjects. Specifically, 18 miRNAs were up-regulated and 126 were down-regulated more than two-fold in HZ patients compared with controls. The subsequent confirmation of these results by qRT-PCR, as well as receiver operating characteristic (ROC) curve analysis, revealed that six kinds of miRNAs, including miR-190b, miR-571, miR-1276, miR-1303, miR-943, and miR-661, exhibited statistically significant enhanced expression levels (more than four-fold) in HZ patients, compared with those of healthy controls and herpes simplex virus (HSV) patients. Subsequently, it is proposed that these circulating miRNAs are capable of regulating numerous pathways and some may even participate in the inflammatory response or nervous system activity. This study has initially demonstrated that the serum miRNA expression profiles in HZ patients were different from those of uninfected individuals. Additionally, these findings also suggest that six of the altered miRNA could be potentially used as biomarkers to test for latent HZ infection.

Influence of HSV-2 on the Mrna Expression of IL-17 and IL-23 Mrna Secreated by HaCaT Cell

Influence of Herpes Simplex Virus Type 2 (HSV-2)on Human Immortalized Keratinocyte Cells Secreting Interleukin (IL)-1 9 and IL-20

Effect of HSV-2 on the Expression of IL-10 and IFN-γ in HaCaT Cells

The Effect of HSV-2 on the Expression of Toll-like Receptors 1～10 in HaCaT Cells

The Effect of HSV-2 on the Expression of KGF and TGF-α in HaCaT Cells

Expression of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor Before and after HaCaT Cell Infection with HSV-2

A study of effects of herpes simplex virus type 2 on IL - 6 secretion by murine antigen presentation cells

IL-17 As a Molecular Adjuvant on Enhancing Cellular Immune Responses to HIV DNA Vaccination

The influence of HCMV infection on autophagy in THP-1 cells.

Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients with Herpes Zoster and Postherpetic Neuralgia

Research progress in human cytomegalovirus and its association with TGF-β and Smad signaling pathway

HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway

Effect of HSV-2 infection on tight junction of genital epithelial cells and chemotaxis of monocytes

Study on significance of high-risk type HSV antibody testing in screening of cervical diseases

In Vitro Study of Effects of Herpes Simplex Virus Type 2 on Murine Dendritic Cells

IL-17A expression by both T cells and non-T cells contribute to HSV-IL-2-induced CNS demyelination

[The Pilot Study on the Correlation Between Human Cytomegalovirus Infection and the Secretion of Chemokines in the Cultured Human Fibroblasts].

Understanding global changes of the mouse brain proteome after vaginal infection with HSV-2 using a label-free shotgun approach

Induction of Immune Response in Mice by Combined Immunization with HSV-2 Multi-Epitope DNA Vaccines and Interleukin-2 Genetic Adjuvant

Risk Factors for Herpes Simplex Virus-1/2 Viremia and Clinical Outcomes Following Unmanipulated Haploidentical Haematopoietic Stem Cell Transplantation.

Evaluation Of Microrna Expression In Patients With Herpes Zoster